{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:41:16Z","timestamp":1790052076191,"version":"4.0.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Normocalcaemic primary hyperparathyroidism (NcPHPT) is a new clinical entity being diagnosed increasingly among patients with mild primary hyperparathyroidism (PHPT). The aim of this study was to evaluate quality of life and non-specific symptoms before and after parathyroidectomy in patients with NcPHPT compared with those with hypercalcaemic mild PHPT (Hc-m-PHPT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective multicentre study of patients with mild PHPT from four university hospitals. Patients were evaluated before operation, and 3, 6 and 12 months after surgery for quality of life using the SF-36-v2\u00ae questionnaire, as well as for 25 non-specific symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Before operation, the only statistically significant difference between the NcPHPT and Hc-m-PHPT groups was in the mean(s.d.) blood calcium level (2\u00b754 versus 2\u00b773 mmol; P &amp;lt; 0\u00b7001). At 1 year after surgery, the blood calcium level had improved significantly in both groups, with no significant difference between them. Quality of life improved significantly in each group compared with its preoperative score, with regard to the physical component summary (P = 0\u00b7040 and P = 0\u00b7016 respectively), whereas the mental component summary improved significantly in the Hc-m-PHPT group only (P = 0\u00b7043). Only two non-specific symptoms improved significantly in the NcPHPT group compared with nine in the Hc-m-PHPT group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Parathyroidectomy mildly improves quality of life and some non-specific symptoms in patients with NcPHPT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/bjs.10739","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T09:44:42Z","timestamp":1517823882000},"page":"223-229","source":"Crossref","is-referenced-by-count":73,"title":["Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism"],"prefix":"10.1093","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-0875","authenticated-orcid":false,"given":"S","family":"Bannani","sequence":"first","affiliation":[{"name":"Clinique de Chirurgie Digestive et Endocrinienne, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Christou","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Digestive, G\u00e9n\u00e9rale et Endocrinienne, CHU Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gu\u00e9rin","sequence":"additional","affiliation":[{"name":"Service de Chirurgie G\u00e9n\u00e9rale, Endocrinienne et M\u00e9tabolique, CHU Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hamy","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Visc\u00e9rale, CHU Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Sebag","sequence":"additional","affiliation":[{"name":"Service de Chirurgie G\u00e9n\u00e9rale, Endocrinienne et M\u00e9tabolique, CHU Marseille, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mathonnet","sequence":"additional","affiliation":[{"name":"Service de Chirurgie Digestive, G\u00e9n\u00e9rale et Endocrinienne, CHU Limoges, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Guillot","sequence":"additional","affiliation":[{"name":"Service de Rhumatologie, H\u00f4tel Dieu, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Caillard","sequence":"additional","affiliation":[{"name":"Clinique de Chirurgie Digestive et Endocrinienne, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Blanchard","sequence":"additional","affiliation":[{"name":"Clinique de Chirurgie Digestive et Endocrinienne, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-4514","authenticated-orcid":false,"given":"E","family":"Miralli\u00e9","sequence":"additional","affiliation":[{"name":"Clinique de Chirurgie Digestive et Endocrinienne, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"2021020617072209900_bjs10739-bib-0001","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2021020617072209900_bjs10739-bib-0002","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4158\/EP15704.OR","article-title":"Primary hyperparathyroidism, with a focus on management of the normocalcemic form: to treat or not to treat?","volume":"22","author":"\u0160iprov\u00e1","year":"2016","journal-title":"Endocr Pract"},{"key":"2021020617072209900_bjs10739-bib-0003","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CCO.0b013e32834c2fb9","article-title":"A summary of the new phenomenon of normocalcemic hyperparathyroidism and appropriate management","volume":"24","author":"Carneiro-Pla","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"2021020617072209900_bjs10739-bib-0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4158\/EP14195.OR","article-title":"Normocalcemic hyperparathyroidism and insulin resistance","volume":"21","author":"Temizkan","year":"2015","journal-title":"Endocr Pract"},{"key":"2021020617072209900_bjs10739-bib-0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-012-9627-x","article-title":"Investigation of insulin resistance in patients with normocalcemic primary hyperparathyroidism","volume":"42","author":"Cakir","year":"2012","journal-title":"Endocrine"},{"key":"2021020617072209900_bjs10739-bib-0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1507\/endocrj.EJ15-0392","article-title":"Patients with normocalcemic primary hyperparathyroidism may have similar metabolic profile as hypercalcemic patients","volume":"63","author":"Yener Ozturk","year":"2016","journal-title":"Endocr J"},{"key":"2021020617072209900_bjs10739-bib-0007","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna","year":"2016","journal-title":"J Bone Miner Metab"},{"key":"2021020617072209900_bjs10739-bib-0008","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1210\/jc.2014-4432","article-title":"Is normocalcemic primary hyperparathyroidism harmful or harmless?","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021020617072209900_bjs10739-bib-0009","doi-asserted-by":"crossref","first-page":"128352","DOI":"10.1155\/2012\/128352","article-title":"Normocalcemic versus hypercalcemic primary hyperparathyroidism: more stone than bone?","volume":"2012","author":"Amaral","year":"2012","journal-title":"J Osteoporos"},{"key":"2021020617072209900_bjs10739-bib-0010","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-09-1067","article-title":"Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"162","author":"Tordjman","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2021020617072209900_bjs10739-bib-0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/S0004-27302011000500003","article-title":"Normocalcemic primary hyperparathyroidism in clinical practice: an indolent condition or a silent threat?","volume":"55","author":"Marques","year":"2011","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"2021020617072209900_bjs10739-bib-0012","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-014-3731-5","article-title":"Quality of life is modestly improved in older patients with mild primary hyperparathyroidism postoperatively: results of a prospective multicenter study","volume":"21","author":"Blanchard","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2021020617072209900_bjs10739-bib-0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-13-0502","article-title":"Surgery for \u2018asymptomatic\u2019 mild primary hyperparathyroidism improves some clinical symptoms postoperatively","volume":"169","author":"Blanchard","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2021020617072209900_bjs10739-bib-0014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","article-title":"Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up)","volume":"141","author":"Caillard","year":"2007","journal-title":"Surgery"},{"key":"2021020617072209900_bjs10739-bib-0015","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archsurg.1992.01420100015003","article-title":"Normocalcemic hyperparathyroidism. Biochemical and symptom profiles before and after surgery","volume":"127","author":"Siperstein","year":"1992","journal-title":"Arch Surg"},{"key":"2021020617072209900_bjs10739-bib-0016","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s002689900428","article-title":"Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism","volume":"22","author":"Pasieka","year":"1998","journal-title":"World J Surg"},{"key":"2021020617072209900_bjs10739-bib-0017","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00268-002-6623-y","article-title":"Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism","volume":"26","author":"Pasieka","year":"2002","journal-title":"World J Surg"},{"key":"2021020617072209900_bjs10739-bib-0018","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"key":"2021020617072209900_bjs10739-bib-0019","first-page":"457","article-title":"Normocalcemic primary hyperparathyroidism","volume":"74","author":"Spivacow","year":"2014","journal-title":"Medicina"},{"key":"2021020617072209900_bjs10739-bib-0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archsurg.137.7.779","article-title":"Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism","volume":"137","author":"Okamoto","year":"2002","journal-title":"Arch Surg"},{"key":"2021020617072209900_bjs10739-bib-0021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1507\/endocrj.44.367","article-title":"Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature","volume":"44","author":"Okamoto","year":"1997","journal-title":"Endocr J"},{"key":"2021020617072209900_bjs10739-bib-0022","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00198-014-3000-2","article-title":"Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism","volume":"26","author":"Cesareo","year":"2015","journal-title":"Osteoporos Int"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbjs.10739","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/105\/3\/223\/36206614\/bjs10739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bjs\/article-pdf\/105\/3\/223\/36206614\/bjs10739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T10:19:08Z","timestamp":1621505948000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/105\/3\/223-229\/6123250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,5]]},"published-print":{"date-parts":[[2018,2,5]]}},"URL":"https:\/\/doi.org\/10.1002\/bjs.10739","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2018,2]]}}}